Table 5.

Determined biomarkers pertaining to the given abnormal patterns are listed with their descriptive ranges.

Abnormal patterns	Indicators	Ranges for control group	Ranges for unhealthy subjects	Descriptive ranges	Accuracy of descriptor (%)
LT	Chloride (mmol/L)	[101–111] median=104	[94–115] median=105	[94–101) or (111–115]	64.52
GGO	LDH (U/L)	[114–187] median=144.5	[81–537] median=241	[81–114) or (187–537]	84:95
Nodules	Sum of avg intensities	[205:4–524:1] median=375.6	[283:9–535:1] median=390	(524:1–535:1]	63.44
PE	HGB (g/dL)	[7:1–11:4] median=9.2	[7:9–13:6] median=10.3	(11:4–13:6] of HGB level and (111–115] or [98–101) of chloride level	82:8
	Chloride (mmol/L)	[101–111] median: 104	[98–115] median: 106
TIB	MCV (fL)	[79:1–95:7] median: 86.4	[84–101] median: 91.2	(95:7–101] of MCV level and [73.9–77.7) of long run emphasis level	72:04
	Long run emphasis	[77.6–127.7] median=102.7	[73.9–124.8] median=99.7
Consolidation	Platelet (K/uL)	[118–337] median: 240	[1–356] median: 93.5	[1–118) or (337–356] of platelet level and [10.2–11.7) or (15.7–19.2] and [0.0119–0.0168) or (0.1863–0.2]	86.02
	RDW (%)	[11.7–15.7] median: 13	[10.2–19.2] median: 14.7
	High gray run emphasis	[0.01–0.18] median: 0.06	[0.01–0.2] median: 0.10